Tunlametinib trials for Melanoma

All Tunlametinib trials · All Melanoma trials

Phase breakdown

Recruiting trials studying Tunlametinib for Melanoma

• Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
  NCT06008106 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors
  NCT07170293 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma
  NCT07445022 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
  NCT07750067 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Tunlametinib for Melanoma?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.